Humana Inc.· HUM

Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.

Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.

For 4 Years, The Villages’ Top Health Provider Allegedly Filed False Medicare Codes. The Bill Just Came Due: $541.5 Million.

A retirement community's top health provider quietly told the government it had been overbilling Medicare for years, then filed for bankruptcy before the consequences arrived. What happened next reshaped who owns the clinics, who absorbs the loss, and what federal prosecutors are targeting next.

If Your Advantage Plan Ends December 31 and You Do Nothing, You Wake Up January 1 in Original Medicare With No Drug Coverage and No Medigap.

Humana's non-renewal letters are already in the mail, and the deadline to act is closer than most affected members realize. Missing it by even one day changes what coverage options remain available and how much they cost.

Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Earns 2026 Great Place To Work Certification™ and PEOPLE Companies That Care® Recognition.

Humana Board Declares Payment of Quarterly Dividend to Stockholders

LOUISVILLE, Ky.--(BUSINESS WIRE)--Humana Inc. (NYSE: HUM) announced today that its Board of Directors has declared a cash dividend to stockholders of $0.885 per share payable on November 27, 2026 to stockholders of record as of the close of business on October 30, 2026. About Humana Humana (NYSE: HUM) is a leading U.S. healthcare company. Through our Humana insurance services and our CenterWell healthcare services, we make it easier for the millions of people we serve to achieve their best heal.

Humana (HUM) PT Raised to $450 at Wolfe Research

Humana price target raised to $405 from $340 at Oppenheimer

Humana price target raised to $415 from $320 at Truist

Humana upgraded to Overweight from Equal Weight at Wells Fargo

Humana price target raised to $300 from $264 at Cantor Fitzgerald